The U.S. Food and Drug Administration has approved Dupixent (dupilumab) as an add-on maintenance treatment for adults ...

The US Food and Drug Administration has approved dupilumab as an add-on maintenance therapy for adults whose chronic ...

The following is a summary of “Vancomycin-resistant Enterococcus (VRE) Pneumonia in a Patient With Advanced Chronic ...

Dupixent is indicated for the approximately 300,000 adults in the U.S. with inadequately controlled chronic obstructive pulmonary disease (COPD) and an eosinophilic phenotype Following recent ...

Retired fire captain Shawn M. Graves celebrates the 8-year anniversary of his life-saving double lung transplant at ...

The following is a summary of "Emergent Pericardial Window in a Patient with Sarcoidosis-like Interstitial Lung Disease, COPD ...

Higher frequency and severity of acute exacerbations of COPD increases the risk for myocardial infarction and pulmonary embolism.

The FDA has approved Dupixent as an add-on maintenance therapy for adults with inadequately controlled COPD and an eosinophilic phenotype.

This deal combines Spire's patient monitoring technology with Wellinks' virtual-led cardiopulmonary care approach, creating ...

Provo residents faced several challenging air quality days beginning Sept. 11, with smoke becoming a concern for residents in Utah County.

Verona Pharma (VRNA – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Ram ...

Sleep apnoea devices giant ResMed has laid out an ambitious growth strategy aiming to broaden its product lines and notch up ...